References
- World Health OrganizationGlobal Tuberculosis Report 2013GenevaWHO2013 Available from: http://www.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf?ua=1Accessed July 9, 2014
- GinsburgASGrossetJHBishaiWRFluoroquinolones, tuberculosis, and resistanceLancet Infect Dis20033743244212837348
- JacobsonKRTierneyDBJeonCYMitnickCDMurrayMBTreatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysisClin Infect Dis201051161420504231
- PoissyJAubryAFernandezCShould moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine modelAntimicrob Agents Chemother201054114765477120805388
- DalhoffAComparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y 3118Clin Infect Dis200132Suppl 1S16S2211249824
- SirgelFAWarrenRMStreicherEMVictorTCvan HeldenPDBöttgerECgyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosisJ Antimicrob Chemother20106751088109322357804
- WangJYLeeLNLaiHCFluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relation to antimicrobial exposureJ Antimicrob Chemother200759586086517412727
- Von GrollAMartinAJureenPFluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrBAntimicrob Agents Chemother200953104498450019687244
- MalikSWillbyMSikesDTsodikovOVPoseyJENew Insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutationsPLoS One201276e3975422761889
- FillionAAubryABrossierFChauffourAJarlierVVezirisNImpact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosisAntimicrob Agents Chemother20135794496450023836169
- World Health OrganizationGuidelines for Surveillance of Drug Resistance in Tuberculosis4th edGenevaWHO2009 Available from: http://www.who.int/entity/tb/publications/2009/surveillance_guidelines/en/index.htmlAccessed February 21, 2013
- AngebyKAJureenPGiskeCGWild-type distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic dataJ Antimicrob Chemother201065594695220332195
- van SoolingenDHermansPWde HaasPESollDRvan EmbdenJDOccurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosisJ Clin Microbiol19912911257825861685494
- RozenSSkaletskyHJPrimer3: Pick primers from a DNA sequence2009 Available from: http://frodo.wi.mit.edu/primer3Accessed January 14, 2014
- Geneious [website on the Internet] Available from: http://www.geneious.comAccessed January 14, 2014
- Van EmbdenJDCaveMDCrawfordJTStrain Identification of Mycobacterium tuberculosis by DNA f ingerprinting: recommendations for a standardized methodologyJ Clin Microbiol19933124064098381814
- Da SilvaPEPalominoJCMolecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugsJ Antimicrob Chemother20116671417143021558086
- MaruriFSterlingTRKaigaAWA systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering systemJ Antimicrob Chemother201267481983122279180
- FeaseyNAPondMColemanDMoxifloxacin and pyrazinamide susceptibility testing in a complex case of multidrug-resistant tuberculosisInt J Tuberc Lung Dis201015341742021333115
- South Africa Department of HealthManagement of Drug-Resistant Tuberculosis: Policy GuidelinesPretoriaDepartment of Health2011
- MendelCSpringskleeMMoxifloxacin for tuberculosisLancet Infect Dis2012123176177 author reply 177–17822361419
- RamtahalMASpread of Multidrug Resistant Tuberculosis (MDR) Including Extensively Drug Resistant Tuberculosis (XDR), in Rural KwaZulu-Natal, South Africa [master’s thesis]DurbanUniversity of KwaZulu-Natal2012
- GandhiNRMollASturmAWExtensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaLancet200636895741575158017084757
- Clinical and Laboratory Standards InstituteMethods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard9th edWayne (PA)CLSI2012 Available from: http://antimicrobianos.com.ar/ATB/wp-content/uploads/2012/11/03-CLSI-M07-A9-2012.pdfAccessed May 14, 2014
- GandhiNRBrustJCMMoodleyPMinimal diversity of drug-resistant Mycobacterium tuberculosis strains, South AfricaEmerg Infect Dis201420342643324565645